Cardiovascular and renal outcomes of dual combination therapies with glucagon-like peptide-1 receptor agonists and sodium-glucose transport protein 2 inhibitors: a systematic review and meta-analysis
Science 279 : 17181721 Kim SO, Merchant K, Nudelman R, Beyer Jr WF, Keng T, DeAngelo J, Hausladen A and Stamler JS (2002) OxyR: a molecular code for redox-related signaling
This age-related decline has attracted serious scientific interest
Patients considering berberine, GLP-1 agonists, or combination therapy should discuss their medical history, current medications, metabolic labs, and weight loss goals with a qualified healthcare provider
We thank the whole PTPSP team at EPFL, especially F